I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues
Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
Info
I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues
Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
Nov 01, 2020 Season 1 Episode 2
Arnall Golden Gregory LLP

In this episode, Alan G. Minsk, partner and leader of the Food & Drug practice team, is joined by Brian A. Teras, partner of the Corporate & Securities practice team. They provide an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process.

Share